Inherited Cardiomyopathy Program

Leading the way in inherited cardiomyopathy research

The NEED
The Inherited Cardiomyopathy Program at the University of Michigan is one of the largest
programs in the country specializing in the treatment of inherited cardiomyopathies,
including hypertrophic cardiomyopathy, familial dilated cardiomyopathy, left ventricular
noncompaction, and arrhythmogenic right ventricular cardiomyopathy.

There is currently no cure for cardiomyopathy. Most treatment programs aim to alleviate
symptoms, prevent complications and slow the progression of the disease. Unwilling to
accept the current treatment options, U-Ms team of cardiomyopathy experts at the Samuel
and Jean Frankel Cardiovascular Center (CVC) are leading the way in finding better treatment
options with a goal of curing all forms of cardiomyopathy through partnering with their
U-M colleagues as well as national and international collaborators.

The clinical and research team at the CVC and C.S. Mott Childrens Hospital provide cutting-
edge genetic assessment, treatment and follow-up care for more than 1,000 children and
adults with inherited cardiomyopathies. Sharlene Day, M.D., cardiologist and associate
professor at the CVC, directs one of the nations few specialized programs for inherited heart
conditions. The physician-scientists work closely with one another, along with specialists in
radiology, exercise physiology, heart failure and genetics to provide the most comprehensive
care to patients and families living with these diseases. The team is determined to forge a
different path to improve quality of life for those with inherited conditions.

The VISION
The vision of the Inherited Cardiomyopathy Program is to empower patients and their
families to enjoy healthy and full lives by providing exceptional clinical care, education, and
individually tailored treatments. We are better positioned now than ever before to uncover
new pathways to treat, and ultimately understand, these genetic conditions and accelerate
discovery to transform patient care. Our multi-faceted research efforts span from stem cell
models of hypertrophic cardiomyopathy, to large, multicenter data repositories, to clinical
trials of medications and lifestyle interventions. Discoveries made at the University of
Michigan have the potential to transform care for patients in the U.S. and around the world.

T h e O P P O RT U N I T Y
With the U-Ms multidisciplinary expertise, we have an opportunity to advance research
and ultimately find cures for cardiomyopathy. An investment in the U-M Inherited
Cardiomyopathy Program will help us develop a personalized approach for every patient: the
right treatment, for the right patient, at the right time.

YOU CAN BE A VICTOR

Today, at the Frankel Cardiovascular Center, we are working toward a cure for inherited
cardiomyopathies. Our mission relies on the generous support of donors. With your support,
we can create the future of cardiomyopathy care and improve the lives of our patients and
their families.

TO PARTNER WITH US, CONTACT:

Michigan Medicine
Office of Development
734-998-7705
medicineneedsvictors.org